More German Companies Get To Work On COVID-19 Diagnostic Test Development

Another three in vitro diagnostics companies in Germany are working on tests for the early detection of COVID-19, with confirmed infections reaching 89,000 globally by 2 March.

Germany

Another three diagnostics firms are developing tests for the rapid detection of the coronavirus, COVID-19 (SARS-CoV-2), which should be ready for launch “in the coming weeks.”

The three companies, which are not yet named, will add to the range of CE-marked or research-use only (RUO) tests...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Germany

More from Europe